Desq Long
Sign in

Company

RIGEL PHARMACEUTICALS INC

RIGL · CIK 0001034842

SEC FORM 4
$8,813.80

RIGEL PHARMACEUTICALS INC (RIGL)

Acquisition (code M) of 694 shares at $12.7 per share.

Reporting Person Schorno Dean L · Officer Title EVP & Chief Financial Officer · Transaction Code M

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0000905148-26-004080 · filed 2026-09-03 · View filing →

SEC FORM 4
$11,594.00

RIGEL PHARMACEUTICALS INC (RIGL)

Acquisition (code M) of 620 shares at $18.7 per share.

Reporting Person Schorno Dean L · Officer Title EVP & Chief Financial Officer · Transaction Code M

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0000905148-26-004080 · filed 2026-09-03 · View filing →

SEC FORM 4
$48,400.00

RIGEL PHARMACEUTICALS INC (RIGL)

Acquisition (code M) of 2,000 shares at $24.2 per share.

Reporting Person Schorno Dean L · Officer Title EVP & Chief Financial Officer · Transaction Code M

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0000905148-26-004080 · filed 2026-09-03 · View filing →

SEC FORM 4
$31,121.20

RIGEL PHARMACEUTICALS INC (RIGL)

Acquisition (code M) of 1,286 shares at $24.2 per share.

Reporting Person Schorno Dean L · Officer Title EVP & Chief Financial Officer · Transaction Code M

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0000905148-26-004080 · filed 2026-09-03 · View filing →

SEC FORM 4
$41,657.50

RIGEL PHARMACEUTICALS INC (RIGL)

Disposition (code F) of 877 shares at $47.50 per share.

Reporting Person Furey Raymond J. · Officer Title EVP, GC, CCO & Corp Sec · Transaction Code F

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0000905148-26-004077 · filed 2026-09-03 · View filing →

SEC FORM 4
$115,140.00

RIGEL PHARMACEUTICALS INC (RIGL)

Disposition (code F) of 2,424 shares at $47.50 per share.

Reporting Person RODRIGUEZ RAUL R · Officer Title CEO, President · Transaction Code F

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0000905148-26-004078 · filed 2026-09-03 · View filing →

SEC FORM 4
$41,515.00

RIGEL PHARMACEUTICALS INC (RIGL)

Disposition (code F) of 874 shares at $47.50 per share.

Reporting Person Santos David A · Officer Title EVP, Chief Commercial Officer · Transaction Code F

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0000905148-26-004079 · filed 2026-09-03 · View filing →

SEC FORM 4
$44,080.00

RIGEL PHARMACEUTICALS INC (RIGL)

Disposition (code F) of 928 shares at $47.50 per share.

Reporting Person Schorno Dean L · Officer Title EVP & Chief Financial Officer · Transaction Code F

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0000905148-26-004080 · filed 2026-09-03 · View filing →